Hydroxysafflor Yellow A (HSYA), a most representative ingredient of Carthamus tinctorius L., had long been used in treating ischaemic cardiovascular diseases in China and exhibited prominently anticoagulant and pro-angiogenic activities, but the underlying mechanisms remained largely unknown. This study aimed to further elucidate the proangiogenic effect and mechanism of HSYA on ischaemic cardiac dysfunction. A C57 mouse model of acute myocardial infarction (AMI) was firstly established, and 25 mg/ kg HSYA was intraperitoneally injected immediately after operation and given once, respectively, each morning and evening for 2 weeks. It was found that HSYA significantly improved ischaemia-induced cardiac haemodynamics, enhanced the survival rate, alleviated the myocardial injury and increased the expressions of CD31, vascular endothelial growth factor-A (VEGF-A) and nucleolin in the ischaemic myocardium. In addition, HSYA promoted the migration and tube formation of human umbilical vein endothelial cells (HUVECs), enhanced the expressions of nucleolin, VEGF-A and matrix metalloproteinase-9 (MMP-9) in a dose-and time-dependent manner. However, down-regulation of nucleolin expression sharply abrogated the effect mentioned above of HSYA. Further protein-RNA coimmunoprecipitation and immunoprecipitation-RT-PCR assay showed that nucleolin binded to VEGF-A and MMP-9 mRNA and overexpression of nucleolin up-regulated the mRNA expressions of VEGF-A and MMP-9 in the HUVECs through enhancing the stability of VEGF-A and MMP-9 mRNA. Furthermore, HSYA increased the mRNA expressions of VEGF-A and MMP-9 in the extract of antinucleolin antibody-precipitated protein from the heart of AMI mice. Our data revealed that nucleolin mediated the pro-angiogenic effect of HSYA through post-transcriptional regulation of VEGF-A and MMP-9 expression, which contributed to the protective effect of HSYA on ischaemic cardiac dysfunction.
| INTRODUCTION
Coronary artery heart disease has become the leading cause of death and disability globally in the last 15 years, 1 and it is mainly attributed to coronary artery stenosis or occlusion-induced myocardial hypoperfusion or ischaemia, which can result in acute myocardial infarction (AMI), myocardial fibrosis and further cardiac dysfunction.
Persistent myocardial ischaemia can subsequently result in irreversible myocardial injury, and the injured myocardial cells are very difficult to regenerate. Consequently, the myocardium supplied by occluded coronary artery becomes disable and even life-threatening. 2, 3 Therefore, more and more attention has been focused on the therapeutic angiogenesis.
Angiogenesis, an essential event involved in various physiological and pathological processes, such as wound healing, formation of granulation tissue and embryogenesis, promotes the growth of new capillary blood vessels and restores the blood flow of ischaemic tissue. [4] [5] [6] It has been proved that neoangiogenesis can effectively restore the blood perfusion of coronary artery and further contribute to the myocardial regeneration. [4] [5] [6] Nowadays, therapeutic neovascularization or neoangiogenesis has been increasingly considered as a promising therapeutic strategy for ischaemic heart diseases due to its effectiveness and invasive property, and more and more attention has been focused on searching for drugs with strong pro-angiogenic activity and little toxicity. [7] [8] [9] Hydroxysafflor Yellow A (HSYA), a most representative and water-soluble ingredient of Carthamus tinctorius L., has long been used in the treatment of myocardial ischaemia in China and exhibits prominently antiplatelet, anti-inflammatory, antioxidant and proangiogenic activities. [10] [11] [12] [13] What is worth to be mentioned is the proangiogenic effect of HSYA which has been reported in different ischaemic models recently. 12, 14 However, the underlying mechanisms
have not yet been fully elucidated.
Nucleolin is a ubiquitously expressed and multifunctional DNA-, RNA-and protein-binding protein in the nucleolus of eukaryotic cells. 15, 16 It is conserved in animals, plants and yeast and plays an essential role in various pathophysiological processes such as assembly of ribosomes, DNA and RNA metabolism, chromatin structure, rDNA transcription, rRNA maturation, nucleogenesis, cell proliferation and apoptosis, tumour growth and angiogenesis. 15 The central region of nucleolin protein contains 4 tandem RNA-binding domains, of which the first 2 determine the RNA-binding specificity and affinity of nucleolin recognition element ((U/G)CCCG(A/G)). Nucleolin regulates the mRNA stability of target genes and consequently mediates their post-transcriptional control through binding the nucleolin recognition element to corresponding binding elements of different target genes. [17] [18] [19] It has been reported that nucleolin can mediate the expressions of angiogenesis-related genes, including vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase-9 (MMP-9). 14, 20, 21 However, whether nucleolin mediates the proangiogenic effect of HSYA through post-transcriptional regulation of these angiogenesis-related genes is largely unknown. In this study, the cardioprotective and pro-angiogenic effect of HSYA on the ischaemic cardiac dysfunction were firstly determined, and then, the role as well as the underlying mechanisms of nucleolin in the pro- Firstly, during the inhalational anaesthesia with isoflurane, the electrocardiogram of mice was recorded. Secondly, under sterile conditions, the heart was exposed through a left thoracotomy in the fourth intercostal space, then the LAD was ligated, the thoracic incision was closed when the elevation of ST segment was found in the electrocardiogram.
The mice were randomly divided into 4 groups as follows: (1) sham-operated group (sham); (2) 
| Measurement of cardiac haemodynamics
According to the protocol we previously reported, 22 were measured, and the maximal slope of systolic pressure increment (+dp/dt) and diastolic pressure decrement (Àdp/dt) were calculated.
| Measurement of myocardial infarct size
The myocardial infarct size was measured by 2% triphenyltetrazolium chloride (TTC) staining as described previously. 23 Positive TTC staining was in red colour, and the infracted area was pale. Images were analysed by Image-Pro Plus, and the infarct size was expressed as a percentage of ischaemic area at risk (% IAR).
| Pathological examination
The HE staining was performed as described previously. 23 Masson's trichrome staining was performed to display the fibration from viable myocardium in the peri-infarct zone. All the pictures were photographed under an optical microscope (Olympus). The extent of collagen deposition was calculated by Image-Pro Plus software (Media Cybernetics, Bethesda, MD, USA).
| Immunohistochemical staining of CD31 and microvessel density determination
The expression of CD31 in the myocardium was detected by immunohistochemistry as described previously. 
| Immuoblotting
Myocardial tissues and HUVECs were homogenized or scraped with the lysis buffer as previously described. 25 Tissue homogenates and cell lysates were centrifuged at 4°C, 14 000 g for 15 minutes.
The concentrations of protein in supernatant were determined by BCA protein assay kit. 20-50 lg protein was loaded to 10% SDS polyacrylamide gel electrophoresis and then transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, USA).
Enhanced or super chemiluminescence (Invitrogen, USA) was used to detect specific proteins according to the manufacture's instruction. The relative band intensity was quantified by Quantity One software.
| Scratch wound-healing assay
As we reported previously, 20 the migration of HUVEC was determined by the scratch wound-healing assay. Six-well plates were seeded with cells to a final density of 2 9 10 5 cells per well, and a 10-lL sterile pipette tip was used to scratch at the mid of each well until the cells were adherent to the plate. Cells in each well were treated by 50 lg/mL HSYA or vehicle and photographed under a microscope at different time-points. The area of wound edges was measured and compared between different time-points. All scratch assays were performed in quadruplicate.
| In vitro angiogenesis assays: tube formation on Matrigel
The tube formation assay was performed according to the manufacture's protocols of BD Matrigel Matrix (BD Biosciences, USA). 
| Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assays were performed to detect the VEGF-A and MMP-9 contents according to the manufacture's protocols.
| Statistical analysis
All data were analysed by SPSS 18.0 software. Measurement data were shown as mean AE SEM of 3 different experiments and analysed by unpaired 2-tailed Student's t tests. Kaplan-Meier analysis was performed to compare the differences in survival rate between different groups. P < .05 was considered statistically significant.
3 | RESULTS
| HSYA improved ischaemia-induced cardiac haemodynamics and enhanced the survival rate of AMI mice
To investigate the protective effect of HSYA on AMI, the cardiac haemodynamics and survival of AMI mice were firstly analysed. As shown in Figure 1A , the survival rate of AMI mice was 37.5%, which was significantly lower than that of the sham-operated controls (100%) (P < .05). However, HSYA treatment obviously elevated the survival rate of AMI mice to 70.6% (P < .05). Moreover, the haemodynamic indexes such as LVSP, +dp/dt and Àdp/dt of saline-treated AMI mice showed significant decline in comparison with the sham-operated controls (P < .05, Figure 1B ,D,E), while the LVEDP was evidently increased (P < .05, Figure 1C ). However, HSYA treatment significantly abrogated the changes of LVSP, LVEDP, +dp/dt and Àdp/dt of AMI mice (P < .05, 
| HSYA diminished the myocardial infarction size and alleviated the myocardial injury
To further determine the protective effect of HSYA on the myocardial ischaemic injury, TTC, Masson and HE staining were performed. It was shown that HSYA markedly attenuated LAD ligation-induced myocardial infarct size in mice (P < .05, Figure 2A ). Masson staining showed more and more collagen production on the 7th and 14th day after LAD ligation, while HSYA treatment alleviated the collagen deposition of AMI mice by 50.05% and 59.98% (P < .05, Figure 2B ). Furthermore, AMI mice showed more overt left ventricular wall thinning and more serious myocardial fibrosis as compared with the sham-operated controls, the myocardial cells were almost completely substituted by the fibroblasts, whereas a greater number of myocardial cells could be observed in HSYA-treated AMI mice, suggesting that HSYA treatment could alleviate LAD ligation-induced acute ischaemic myocardial injury ( Figure 2C ).
| HSYA increased the angiogenesis and nucleolin expression in the ischaemic myocardium of AMI mice
Angiogenesis was proved to be beneficial to improve the ischaemic myocardial injury. 26 So the expression of angiogenic markers (CD31, VEGF-A) in the ischaemic myocardium was detected. It was shown that both the MVD (CD31+ endothelial cells) and VEGF-A expressions (mRNA and protein) of ischaemic myocardium in HSYA-treated AMI mice were substantially elevated than those of saline-treated AMI mice (P < .05, Figure 3A -D). In our previous study, nucleolin was proved to play a pro-angiogenic role during the recovery of heat-denatured dermis through enhancing the production of VEGF-A. 20 So in this study, the expression of nucleolin was also detected, and we ZOU ET AL. 
F I G U R E 2 Hydroxysafflor Yellow A diminished the myocardial infarct size and alleviated the myocardial injury. (A)
Representative images of TTC-stained heart sections (left) and the statistics histogram of myocardial infarct size of mice with or without HSYA treatment for 7 days (right) (n = 5 per group; *P < .05 vs Sham+NS, # P < .
vs AMI + NS). (B)
Representative images of Masson's Trichrome-stained mice heart sections (upper) and the fibrosis of whole myocardium subjected to ischaemia with or without HSYA treatment for 7 and 14 days (nether) (n = 5 per group; *P < .05 vs Sham + NS, # P < .05 vs AMI + NS). (C) Representative images of HE staining of heart sections subjected to ischaemia with or without HSYA treatment for 7 days (Scale bar = 100 lm) To further identify that the regulation of nucleolin on the mRNA of VEGF-A and MMP-9 was involved in the pro-angiogenic effect of HSYA, the interaction between nucleolin and mRNA of VEGF-A and MMP-9 in HSYA-treated AMI mice was determined by IP-RT-PCR.
We found that nucleolin in the heart tissues of AMI mice and HSYA-treated AMI mice was successfully precipitated through protein A/G magnetic beads, and the expressions of MMP-9 and VEGF-A mRNA were detectable in the extracted from the magnetic beads, suggesting that nucleolin could bind to the MMP-9 and VEGF-A mRNA in the heart of saline-and HSYA-treated AMI mice (Figure 7I) . Moreover, both the expressions of MMP-9 and VEGF-A mRNA were relatively weak in the extract of nucleolin antibody-precipitated protein from the heart tissue of AMI mice, which were ity. 29 However, excessive angiogenesis may result in different diseases such as cancer, atherosclerosis, rheumatoid arthritis and endometriosis. 30, 31 Therefore, therapeutic angiogenesis should aim to achieve effective and moderate angiogenesis. Angiogenesis is a pro-angiogenic factor (mainly VEGF, bFGF, MMP, etc) and antiangiogenic factors (mainly angiostatin, endostatin, thrombospondin-1, etc) coregulated and balanced process. Among these factors, VEGF-A and MMP-9 are considered as important regulators of blood vessel formation, which can promote the proliferation, migration and tube-like structure formation of vascular endothelial cells. As a result, they are considered as potential targets for angiogenesis-related diseases. 37, 38 In the present study, we found that HSYA significantly increased the VEGF-A and MMP-9 mRNA and protein expressions in the ischaemic myocardium, which might contribute to the pro-angiogenic effect of HSYA. These results were partly similar to those Wei et al 14 had reported. However, how HSYA mediated the expression of VEGF-A and MMP- 9 had not yet been fully elucidated.
In our previous study, nucleolin which was a multifunctional phosphoprotein abundantly expressed in the nucleolus, nucleus, cytoplasm and cytomembrane was found to be able to promote the angiogenesis during the recovery of heat-denatured HUVECs through up-regulation the expression of VEGF. 20, 36 Cell surface nucleolin is even proved to be a specific marker of angiogenic endothelial cells in the vasculature. 39 Moreover, nucleolin displayed remarkably cardioprotective, antiapoptotic and tumour inhibitory effects, etc. 18, 23, 40, 41 In the present study, we found that HSYA dominantly increased the nucleolin expression in the ischaemic myocardium and HUVECs. In addition, down-regulating the expression of nucleolin in HUVECs abrogated HSYA-promoted tube formation.
These results suggested that nucleolin might be involved in the cardioprotective and pro-angiogenic effect of HSYA. It is also worthy to be noted that HSYA exhibited obvious antiangiogenesis on different cancer models. Besides what we had mentioned above, the inhibitory effect of HSYA on the abnormal proliferation of HUVECs and angiogenesis was reported by Wang et al. 46 Yang et al. 47 found that HSYA inhibited the angiogenesis of hepatocellular carcinoma through blocking ERK/MAPK and NF-jB signalling pathway in H22 tumour-bearing mice. Furthermore, the antiangiogenic effect of HSYA was found in the transplantation tumour of gastric adenocarcinoma cell line BGC-823-induced nude mice. 48 We speculated that there may be a switch point for HSYA to balance angiogenesis. Nevertheless, the on-off switch for the effect of HSYA on the angiogenesis was still unknown, which could not be ignored and should be more focused on in the further study.
In summary, the present study showed that HSYA could ame- 
